This article reviews the definition of HCPs, risks posed by HCPs, regulatory concerns, commonly accepted ELISA methods for HCP measurement and their limitations, and orthogonal methods available for HCP characterization.
Fengqiang Wang, PhD
Advertisement
Fengqiang Wang, PhD, is associate principal scientist,Sterile Product and Analytical Development, Merck Research Laboratories, 2000 Galloping Hill Road, K15-4-E214Kenilworth, NJ 07033; fengqiang.wang@merck.com
Articles by Fengqiang Wang, PhD
Advertisement
Latest Updated Articles
Host-Cell Protein Measurement and ControlPublished: June 1st 2015 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
Why Radiopharmaceuticals Are Ideal for Treating Cancer
4
Check Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery
5
